112 related articles for article (PubMed ID: 36336105)
1. Synthesis and biological activity of 21,22-cyclosteroids and their derivatives.
Barysevich MV; Laktsevich-Iskryk MV; Scherbakov AM; Salnikova DI; Andreeva OE; Sorokin DV; Shchegolev YY; Hurski AL; Zhabinskii VN; Khripach VA
Steroids; 2022 Dec; 188():109135. PubMed ID: 36336105
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of B-ring-modified steroids through BF3-promoted rearrangement/substitution of 6β-hydroxy-5,19-cyclosteroids.
Kranz DP; Chiha S; Meier zu Greffen A; Neudörfl JM; Schmalz HG
Org Lett; 2012 Jul; 14(14):3692-5. PubMed ID: 22765256
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
4. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
5. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
Kandil S; Westwell AD; McGuigan C
Bioorg Med Chem Lett; 2016 Apr; 26(8):2000-4. PubMed ID: 26965862
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones.
Kuzminac IZ; Jakimov DS; Bekić SS; Ćelić AS; Marinović MA; Savić MP; Raičević VN; Kojić VV; Sakač MN
Bioorg Med Chem; 2021 Jan; 30():115935. PubMed ID: 33340938
[TBL] [Abstract][Full Text] [Related]
7. Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells.
Komendantova AS; Scherbakov AM; Komkov AV; Chertkova VV; Gudovanniy AO; Chernoburova EI; Sorokin DV; Dzichenka YU; Shirinian VZ; Volkova YA; Zavarzin IV
Bioorg Chem; 2019 Oct; 91():103142. PubMed ID: 31400555
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
9. A carbon 21 steroidal metabolite from progestin, 20β-hydroxy-5α-dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells.
Ando T; Nishiyama T; Takizawa I; Miyashiro Y; Hara N; Tomita Y
Prostate; 2018 Feb; 78(3):222-232. PubMed ID: 29194690
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents.
Rudovich AS; Peřina M; Krech AV; Novozhilova MY; Tumilovich AM; Shkel TV; Grabovec IP; Kvasnica M; Mada L; Zavialova MG; Mekhtiev AR; Jorda R; Zhabinskii VN; Khripach VA
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362320
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan MT; García-Becerra R; Ordaz-Rosado D; Noyola-Martínez N; Castillo-Bocanegra R; Barrera D
J Steroid Biochem Mol Biol; 2016 May; 159():8-18. PubMed ID: 26924581
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of new D-seco and D-homo androstane derivatives.
Djurendić EA; Zavis MP; Sakac MN; Canadi JJ; Kojić VV; Bogdanović GM; Penov Gasi KM
Steroids; 2009 Nov; 74(12):983-8. PubMed ID: 19646459
[TBL] [Abstract][Full Text] [Related]
13. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Ylitalo EB; Thysell E; Thellenberg-Karlsson C; Lundholm M; Widmark A; Bergh A; Josefsson A; Brattsand M; Wikström P
Prostate; 2020 Feb; 80(2):214-224. PubMed ID: 31799745
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of methoxycarbonylpyrazolylandrostene derivatives, and their potential inhibitory effect on androgen biosynthesis and cell proliferation.
Szabó N; Iványi Z; Szécsi M; Julesz J; Mernyák E; Huber J; Wölfling J; Minorics R; Zupkó I; Schneider G
Steroids; 2015 Jun; 98():143-52. PubMed ID: 25804762
[TBL] [Abstract][Full Text] [Related]
15. A-ring-fused pyrazoles of dihydrotestosterone targeting prostate cancer cells via the downregulation of the androgen receptor.
Peřina M; Kiss MA; Mótyán G; Szczyrbová E; Eliáš M; Študent V; Kurfürstová D; Kovalová M; Mada L; Bouchal J; Frank É; Jorda R
Eur J Med Chem; 2023 Mar; 249():115086. PubMed ID: 36682291
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic effect of pregnenolone derivatives with one or two α,β-unsaturated carbonyls and an ester moiety at C-21 or C-3.
Chávez-Riveros A; Cruz Noriega A; Ramírez Apan MT; Miranda LD; Bratoeff E
Steroids; 2018 Mar; 131():37-45. PubMed ID: 29360536
[TBL] [Abstract][Full Text] [Related]
17. Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells.
Sasaki T; Yoshikawa Y; Kageyama T; Sugino Y; Kato M; Masui S; Nishikawa K; Inoue T
Prostate; 2023 Mar; 83(4):364-375. PubMed ID: 36479717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
Kim HJ; Park YI; Dong MS
Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
[TBL] [Abstract][Full Text] [Related]
20. Steroids with modified ring A or B: screening for potential antiandrogenic and synandrogenic activity.
Stárka L; Hampl R; Bicíková M; Cerný V; Fajkos J; Kasal A; Kocovský P; Kohout L; Velgová H
J Steroid Biochem; 1980 Apr; 13(4):455-60. PubMed ID: 7190203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
